0 XP 0   0   0  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Benitec Biopharma Ltd ADR - Trending symbols

Latest News of Benitec Biopharma Ltd ADR

DateTitleRead
2025-11-05
22:43
Benitec Biopharma Inc. Announces Proposed Public OfferingRead
2025-11-03
13:10
Benitec Biopharma Provides Positive Interim Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial and Receives FDA Fast Track Designation for BB-301Read
2025-11-03
13:00
Benitec Biopharma Announces Appointment of Sharon Mates Ph.D. to its Board of DirectorsRead
2025-11-03
01:00
Benitec Biopharma to Provide Phase 1b/2a Clinical Study Update for BB-301 in Oculopharyngeal Muscular DystrophyRead

Notifications

TypeNotificationDate
RSI OversoldOversold RSI (Relative Strength Index)2025-11-07



Trends

 2024-06-302024-09-302024-12-312025-03-312025-06-30
Gross Profit -910-9110-81-25-106384278
Depreciation and Amortization 91091-108125106-384-278
Net Interest Income -82-60-62-4924920
Net Working Capital 16,092-6,4199,6739,56619,239-16,9512,288-2,537-249
Interest Expense 909-2718-14-6
Total Other Income Expense Net -7-109-116-32-148-75-22323714

Comments

How you think about this?

Leave a comment

Stay informed about Benitec Biopharma Ltd ADR.

Receive notifications about Benitec Biopharma Ltd ADR in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.